Stock & Company Details
Avalyn Pharma Inc. $AVLN
Price:
N/A
N/A
N/A
$1.1B
52 Week High:
N/A
10 Day Average Volume:
N/A
N/A
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
N/A
AVLN technical indicators
Latest Avalyn Pharma Inc. (AVLN) indicator readings as of 2026-10-09.
AVLN's 14-day RSI is 32.1, in neutral territory. Price sits in the middle of its Bollinger Bands ($23.14 to $35.68). ADX reads 40.3, indicating a trending market.
Overview
Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.
Finance Bot
Ask your questions
Start by typing a question below.
